Medicines List

Select category
  • Description

    RosstAacy contains two active substances – rosuvastatin and acetylsalicylic acid.

    Indications

    Rosuvastatin belongs to a group of substances called statins, which are lipid (fat) regulating medicines that are used to lower lipids known as cholesterol and triglycerides in the blood. Cholesterol is a fatty substance (lipid) that can cause the narrowing of blood vessels in the heart causing coronary heart disease. If there is another risk of heart attack, rosuvastatin can also be used to reduce such risk even if cholesterol levels are normal. A standard cholesterol-lowering diet should be followed during treatment.

    Acetylsalicylic acid in low doses belongs to a group of medicines called anti-platelet agents. Platelets are tiny cells in the blood that cause the blood to clot and are involved in thrombosis. When a blood clot occurs in an artery it stops the blood flowing and cuts off the oxygen supply. When this happens in the heart it can cause a heart attack or angina.

    RosstAacy is indicated in patients who are already taking rosuvastatin and acetylsalicylic acid at these doses. Instead of taking rosuvastatin and acetylsalicylic acid separately you will receive one capsule of RosstAacy which contains both ingredients in the same strength.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 5 mg/100 mg; 10 mg/100 mg; 20 mg/100 mg hard capsules

    Patient information leaflet

  • Description

    Clopasa contains the active substance colchicine and belongs to the group of medicines known as antigout drugs.

    Indications

    Clopasa is used for the treatment of acute gout attacks and chronic gout, prophylaxis of acute attacks,  when starting treatment with other medicines decreasing uric acid in blood and urine, and Familiar Mediterranean Fever.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 0,5 mg tablets

  • Description

    Reverantza contains two substances called olmesartan medoxomil and amlodipine.
    Both of these substances help to control high blood pressure.

    Olmesartan medoxomil belongs to a group of medicines called ‘angiotensin-II receptor antagonists’ which lower blood pressure by relaxing the blood vessels.

    Amlodipine belongs to a group of substances called ‘calcium channel blockers’. Amlodipine stops calcium from moving into the blood vessel wall which stops the blood vessels from tightening thereby also reducing blood pressure.

    Indications

    Treatment of essential hypertension.
    Reverantza is indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil or amlodipine monotherapy.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 20 mg/5 mg; 40 mg/5 mg film-coated tablets.

  • Description

    Methylprednisolone-Tchaikapharma belongs to a group of medicines called corticosteroids or steroids.

    Indications

    Methylprednisolone-Tchaikapharma is used to treat the following conditions:
    – Hormonal diseases;
    – Rheumatic diseases;
    – Collagenosis;
    – Skin diseases;
    – Allergic conditions;
    – Eye diseases;
    – Intestinal diseases;
    – Pulmonary inflammation;
    – Blood disorders;
    – Malignancies;
    – Swelling;
    – Other conditions.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 40 mg powder and solvent for solution for injection